Detailed information on the eligibility criteria can be found in the Methods
Aptamer-based targeted protein degradation
Visible absorption spectrophotometry around 500-600 nm is the standard bench check on complex integrity
Neurological Disclaimer: Injectable glutathione is not approved for the treatment, prevention, or cure of any neurological condition including cognitive decline, neurodegenerative diseases, or mood disorders
In a 2001 study published in Endocrinology , Heffernan and colleagues reported that chronic AOD-9604 administration reduced body weight gain, decreased adipose tissue mass, and increased fat oxidation in obese mice without altering IGF-1 levels or glucose metabolism effects that were abolished in beta3 adrenergic receptor (3-AR) knockout mice, implicating 3-AR signaling as the mechanism of action [1]
Guaranteed Safe Checkout Important Notice: This product is sold strictly for laboratory research purposes only